Clinical efficacy of individual cognitive therapy in reducing psychiatric symptoms in people at ultra-high risk for psychosis

Early Intervention in Psychiatry

Volumn 5, Issue 2, 2011, Pages 174-178

  Kim, Kyung Ran ^a   Lee, Su Young ^a   Kang, Jee In ^a,b   Kim, Bo Ra ^a,b   Choi, Soo Hee ^a   Park, Jin Young ^a,c   Lee, Eun ^a   An, Suk Kyoon ^a   Kwon, Jun Soo ^d  

^a Yonsei University College of Medicine   (South Korea)

^b National Health Insurance Corporation   (South Korea)

^c Kongju National Hospital   (South Korea)

^d Seoul National University   (South Korea)

Author keywords

Cognitive therapy; Early intervention; Prodrome; Schizophrenia; Ultra high risk for psychosis

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; COGNITIVE THERAPY; DEPRESSION; DISEASE SEVERITY; EARLY INTERVENTION; EFFECT SIZE; FEMALE; HIGH RISK POPULATION; HUMAN; MALE; NEGATIVE SYNDROME; POSITIVE SYNDROME; PRIORITY JOURNAL; PSYCHOSIS; SOUTH KOREA; SYMPTOM; THERAPY EFFECT; TREATMENT OUTCOME;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; COGNITIVE THERAPY; EARLY DIAGNOSIS; FEMALE; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; RISK;

EID: 79955452591     PISSN: 17517885     EISSN: 17517893     Source Type: Journal    
DOI: 10.1111/j.1751-7893.2011.00267.x     Document Type: Article

References (24)

1. McGorry PD, Yung AR, Phillips LJ etal. Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry 2002; 59: 921-8.
2. McGlashan TH, Zipursky RB, Perkins D etal. Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. Am J Psychiatry 2006; 163: 790-9.
3. McGlashan TH, Addington J, Cannon T etal. Recruitment and treatment practices for help-seeking 'prodromal' patients. Schizophr Bull 2007; 33: 715-26.
4. Yung AR, McGorry PD, McFarlane CA, Jackson HJ, Patton GC, Rakkar A. Monitoring and care of young people at incipient risk of psychosis. Schizophr Bull 1996; 22: 283-303.
5. Miller TJ, McGlashan TH, Rosen JL etal. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr Bull 2003; 29: 703-15.
6. Cannon TD, Cadenehad K, Cronblatt B etal. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry 2008; 65: 28-37.
7. Yung AR, Phillips LJ, Yuen HP, McGorry PD. Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophr Res 2004; 67: 131-42.
8. Woods SW, Addington J, Cadenhead KS etal. Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. Schizophr Bull 2009; 35: 894-908.
9. Angermeyer MC, Matschinger H. The effect of diagnostic labelling on the lay theory regarding schizophrenic disorders. Soc Psychiatry Psychiatr Epidemiol 1996; 31: 316-20.
10. Morrison AP, French P, Walford L etal. Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial. Br J Psychiatry 2004; 185: 291-7.
11. Morrison AP, French P, Parker S etal. Three-year follow-up of a randomized controlled trial of cognitive therapy for the prevention of psychosis in people at ultrahigh risk. Schizophr Bull 2007; 33: 682-7.
12. Addington J, Epstein I, Liu L, French P, Boydell KM, Zipursky RB. A randomized controlled trial of cognitive behavioral therapy for individuals at clinical high risk of psychosis. Schizophr Res 2011; 52: 33-40.
13. An SK, Kang JI, Park JY, Kim KR, Lee SY, Lee E. Attribution bias in ultra-high risk for psychosis and first-episode schizophrenia. Schizophr Res 2010; 118: 54-61.
14. Broome MR, Johns LC, Valli I etal. Delusion formation and reasoning biases in those at clinical high risk for psychosis. Br J Psychiatry 2007; 51: s38-42.
15. Turkington D, Kingdon D, Weiden PJ. Cognitive behavior therapy for schizophrenia. Am J Psychiatry 2006; 163: 365-73.
16. French P, Morrison AP. Early Detection and Cognitive Therapy for People at High Risk of Developing Psychosis. A Treatment Approach. London: Wiley, 2004.
17. Kim K, Park J, Song D, Koo H, An S. Neurocognitive performance in subjects at ultrahigh risk for schizophrenia: a comparison with first-episode schizophrenia. Compr Psychiatry 2011; 125: 54-61.
18. Lee SY, Namkoong K, Cho HH, Song DH, An SK. Reduced visual P300 amplitudes in individuals at ultra-high risk for psychosis and first-episode schizophrenia. Neurosci Lett 2010; 486: 156-60.
19. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13: 261-76.
20. Beck AT, Steer RA. Internal consistencies of the original and revised Beck Depression Inventory. J Clin Psychol 1984; 40: 1365-7.
21. Bentall RP, Corcoran R, Howard R, Blackwood N, Kinderman P. Persecutory delusions: a review and theoretical integration. Clin Psychol Rev 2001; 21: 1143-92.
22. Rector NA, Beck AT. Cognitive behavioral therapy for schizophrenia: an empirical review. J Nerv Ment Dis 2001; 189: 278-87.
23. Kroken RA, Johnsen E, Ruud T, Wentzel-Larsen T, Jorgensen HA. Treatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national study. BMC Psychiatry 2009; 9: 24.
24. Bechdolf A, Phillips LJ, Francey SM etal. Recent approaches to psychological interventions for people at risk of psychosis. Eur Arch Psychiatry Clin Neurosci 2006; 256: 159-73.